Dr. Wu Skincare Co., Ltd. (TPEX:6523)
Taiwan · Delayed Price · Currency is TWD 117.00
-0.50 (-0.43%)
Feb 11, 2026, 1:30 PM CST
Dr. Wu Skincare Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 403.66 | 476.25 | 424.73 | 339.98 | 296.24 | 661.11 |
Depreciation & Amortization | 8.78 | 8.42 | 9.42 | 9.77 | 12.16 | 14 |
Loss (Gain) From Sale of Assets | - | - | - | - | 0.14 | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.97 | - |
Loss (Gain) From Sale of Investments | -0.21 | -1.09 | -0.89 | 1.88 | 1.06 | -577.27 |
Loss (Gain) on Equity Investments | - | - | - | - | - | 9.3 |
Provision & Write-off of Bad Debts | 0.02 | -0.05 | 0.05 | -0.07 | 0.07 | -0.11 |
Other Operating Activities | -13 | -25.09 | 17.23 | 7.06 | -82.31 | 115.18 |
Change in Accounts Receivable | -39.91 | -33.53 | -11.15 | 18.72 | -46.66 | 84.7 |
Change in Inventory | 29.8 | 26.97 | -73.56 | -0.02 | -12.17 | -0.78 |
Change in Accounts Payable | 14.41 | -36.8 | 15.98 | -43.24 | 61.43 | -13.7 |
Change in Unearned Revenue | 10.04 | 3.26 | 0.21 | -5.55 | 1.15 | 3.64 |
Change in Other Net Operating Assets | -92.58 | 18.84 | 10.42 | -2.7 | 62.09 | 4.84 |
Operating Cash Flow | 321.02 | 437.18 | 392.44 | 325.83 | 294.17 | 300.91 |
Operating Cash Flow Growth | -21.98% | 11.40% | 20.44% | 10.76% | -2.24% | 34.60% |
Capital Expenditures | -4.31 | -2.75 | -2.95 | -1.59 | -3.26 | -1.78 |
Divestitures | - | - | - | - | 250.83 | 256.59 |
Sale (Purchase) of Intangibles | - | - | -0.33 | - | -0.11 | -0.13 |
Investment in Securities | -19.97 | -86.47 | -105.54 | -330.5 | 557.02 | 160.06 |
Other Investing Activities | -4.06 | 0.02 | 0.17 | -0.63 | 3 | 3.43 |
Investing Cash Flow | -28.34 | -89.21 | -108.64 | -332.73 | 807.48 | 418.16 |
Long-Term Debt Repaid | - | -9.84 | -9.99 | -9.83 | -9.41 | -9.15 |
Net Debt Issued (Repaid) | -9.73 | -9.84 | -9.99 | -9.83 | -9.41 | -9.15 |
Common Dividends Paid | -495.52 | -495.52 | -450.48 | -360.38 | -775.72 | -624.36 |
Other Financing Activities | - | - | - | - | -0.23 | -0.24 |
Financing Cash Flow | -505.26 | -505.36 | -460.47 | -370.21 | -785.36 | -633.75 |
Net Cash Flow | -212.58 | -157.39 | -176.67 | -377.1 | 316.3 | 85.32 |
Free Cash Flow | 316.71 | 434.43 | 389.49 | 324.24 | 290.92 | 299.13 |
Free Cash Flow Growth | -22.60% | 11.54% | 20.13% | 11.45% | -2.74% | 46.84% |
Free Cash Flow Margin | 25.62% | 34.98% | 34.25% | 34.98% | 26.30% | 39.12% |
Free Cash Flow Per Share | 7.00 | 9.62 | 8.64 | 7.19 | 6.45 | 6.62 |
Cash Interest Paid | 1.42 | 0.82 | 0.26 | 0.52 | 0.76 | 1 |
Cash Income Tax Paid | 118.26 | 143.33 | 82.2 | 79.16 | 158.33 | 16.92 |
Levered Free Cash Flow | 598.87 | 405.5 | 167.7 | 203.32 | 526.44 | 47.68 |
Unlevered Free Cash Flow | 599.76 | 406.01 | 167.86 | 203.65 | 526.91 | 48.3 |
Change in Working Capital | -78.24 | -21.26 | -58.09 | -32.79 | 65.85 | 78.69 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.